Torren Management’s West Pharmaceutical WST Stock Holding History

Torren Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-124	Closed	-$34.1K	–	1455
2025 Q4	$34.1K	Buy	+124	New	+$33.9K	0.02%	442

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Torren Management's WST Position: Q1 2026 in Review

Torren Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 124 shares — an estimated $34.1K sold.

Torren Management first reported a position in WST in Q4 2025 and held it in 1 quarter. The position peaked at $34.1K in Q4 2025. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Torren Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
Torren Management sold 124 West Pharmaceutical shares in Q1 2026, an estimated $34.1K.
Torren Management first reported a position in West Pharmaceutical in Q4 2025 and held it in 1 quarter.
Torren Management's West Pharmaceutical position peaked at $34.1K in Q4 2025.
754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.